Get started
Author

Leonie Saft

Observed names: L Saft, L. Saft, Saft, L., Saft, Leonie
ORCID: 0000-0002-4357-1570
Observed ORCID: 0000-0002-4357-1570
OpenAlex ID: A5087022188
TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
2011 · Martin Jädersten, Leonie Saft, et al. · Journal of Clinical Oncology · 463
Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study
2012 · M. G. Della Porta, C. Picone, et al. · Haematologica · 166
PDF
p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)
2014 · L. Saft, M. Karimi, et al. · Haematologica · 138
PDF
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group
2016 · Theresia M. Westers, Eline M.P. Cremers, et al. · Haematologica · 102
PDF
Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression
2009 · M. Jadersten, L. Saft, et al. · Haematologica · 100
PDF
SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells
2017 · Teresa Mortera-Blanco, Marios Dimitriou, et al. · Blood · 77
PDF
Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid
2014 · Susanna Ranta, Frans Nilsson, et al. · Pediatric Blood & Cancer · 64
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues
2022 · Anna Porwit, Marie C. Béné, et al. · Cytometry Part B Clinical Cytometry · 55
PDF
Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial
2014 · M Tobiasson, I Dybedahl, et al. · Blood Cancer Journal · 55
PDF
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
2011 · L. Mollgard, L. Saft, et al. · Haematologica · 51
PDF
Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet
2021 · Vincent H. J. van der Velden, Frank Preijers, et al. · Cytometry Part B Clinical Cytometry · 49
PDF
Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
2016 · Christian Scharenberg, Valentina Giai, et al. · Haematologica · 47
PDF
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow Cytometry Working Group
2021 · Arjan A. van de Loosdrecht, Wolfgang Kern, et al. · Cytometry Part B Clinical Cytometry · 40
PDF
Mutations in idiopathic cytopenia of undetermined significance assist diagnostics and correlate to dysplastic changes
2016 · Jakob Werner Hansen, Maj Karoline Westman, et al. · American Journal of Hematology · 40
PDF
Bone marrow dendritic cells are reduced in patients with high-risk myelodysplastic syndromes
2012 · Leonie Saft, Elisabet Björklund, et al. · Leukemia Research · 38
A pilot phase I dose finding safety study of the thrombopoietin‐receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine
2014 · Tobias Svensson, Onima Chowdhury, et al. · European Journal Of Haematology · 34
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group
2022 · Wolfgang Kern, Theresia M. Westers, et al. · Cytometry Part B Clinical Cytometry · 33
Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders
2020 · Katalin Kelemen, Leonie Saft, et al. · American Journal of Clinical Pathology · 33
PDF
TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations
2016 · Jenny Dahlström, Tiantian Liu, et al. · Annals of Hematology · 28
PDF
The AML–MDS interface—leukemic transformation in myelodysplastic syndromes
2011 · Anna Porwit, Leonie Saft · Journal of Hematopathology · 27
PDF
CD 274 ( PD ‐L1)/ PDCD 1 ( PD ‐1) expression in de novo and transformed diffuse large B‐cell lymphoma
2016 · Anna Kwiecinska, Nikolaos Tsesmetzis, et al. · British Journal of Haematology · 24
PDF
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features
2014 · Agata M. Wasik, Lina Nygren, et al. · Oncoscience · 24
PDF
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases
2023 · Leonie Saft, Hans M Kvasnicka, et al. · Histopathology · 22
PDF
Dendritic Cells in Bone Marrow at Diagnosis and after Chemotherapy in Adult Patients with Acute Myeloid Leukaemia
2014 · Å. R. Derolf, E. Laane, et al. · Scandinavian Journal of Immunology · 22
PDF
Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial
2022 · Martin Jädersten, Ingrid Lilienthal, et al. · Journal of Internal Medicine · 18
PDF
Works count: 75
Citation count: 1,941
H-index: 22
I10-index: 34
Year
Topic
Type